Post‐transplant‐cyclophosphamide and short‐term Everolimus as graft‐versus‐host‐prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the phase II OCTET‐EVER trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Tim Richardson, Christof Scheid, Marco Herling, Lukas P. Frenzel, Carmen Herling, Marta Rebecca Cruz Aguilar, Sebastian Theurich, Michael Hallek, Udo Holtick
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	European Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet